|
Published by: Frost & Sullivan
Published: Nov. 13, 2009 - 83 Pages
Table of Contents
- 1. Executive Summary
- U.S. Overactive Bladder Market
- Introduction
- 2. Market Introduction Research
- Scope and Methodology
- Scope and Segmentation
- Research Methodology
- Market Overview
- Market Engineering Measurements
- Disease Overview
- Treatment Options
- Patient Forecasts
- Industry Challenges
- Market Drivers
- Market Restraints
- Product Analysis
- Product Analysis
- Product Comparisons
- Recently Approved Products
- Pipeline Analysis
- Phase III
- Phase II
- Phase I
- 3. Competitive Analysis
- Overview
- Competitive Structure
- Forecasts and Trends
- Total Market
- Revenue Forecasts by Product
- Market Share Analysis
- Company Market Share
- Product Market Share
- Drug Delivery Market Share
- 4. Appendix
- Decision Support Databases
- Population 65 Plus
- Female Population 65 Plus
- Male Population 65 Plus
- Total Life Expectancy at Birth
- Birth Rate
- List of Figures
- Chapter 2
- Overactive Bladder Market: Patient Forecasts by Gender (U.S.), 2005-2015
- Overactive Bladder Market: Male Patient Forecasts by Age (U.S.), 2005-2015
- Overactive Bladder Market: Female Patient Forecasts by Age (U.S.), 2005-2015
- Overactive Bladder Market: Treated Versus Total Patient Forecasts (U.S.), 2005-2015
- Overactive Bladder Market: Treated Patient Population Share by Product (U.S.), 2008
- Overactive Bladder Market: Impact of Top Four Industry Challenges (U.S.), 2009-2015
- Overactive Bladder Market: Market Drivers Ranked in Order of Impact (U.S.), 2009-2015
- Overactive Bladder Market: Market Restraints Ranked in Order of Impact (U.S.), 2009-2015
- Overactive Bladder Market: Product Analysis (U.S.), 2008
- Overactive Bladder Market: Reported Drug Efficacy as a Mean Reduction in Incontinence Episodes (U.S.), 2008
- Overactive Bladder Market: Percent of Patients Experiencing the Most Common Side Effects for Overactive Bladder Medications (U.S.), 2008
- Overactive Bladder Market: Recently Approved Product Analysis (U.S.), 2009
- Overactive Bladder Market: Phase III Pipeline Analysis (U.S.), 2009
- Overactive Bladder Market: Phase II Pipeline Analysis (U.S.), 2009
- Overactive Bladder Market: Phase I Pipeline Analysis (U.S.), 2009
- Chapter 3
- Overactive Bladder Market: Competitive Structure (U.S.), 2008
- Overactive Bladder Market: Revenue Forecasts (U.S.), 2005-2015
- Overactive Bladder Market: Revenue Forecasts for Branded Products (U.S.), 2005-2015
- Overactive Bladder Market: Revenue Forecasts for Generic Products (U.S.), 2005-2015
- Overactive Bladder Market: Company Market Share by Revenues (U.S.), 2008
- Overactive Bladder Market: Company Market Share by Revenues (U.S.), 2015
- Overactive Bladder Market: Product Market Share by Revenues (U.S.), 2008
- Overactive Bladder Market: Product Market Share by Revenues (U.S.), 2015
- Overactive Bladder Market: Revenues by Delivery Type (U.S.), 2008/2015
AbstractThis research service covers the U.S. overactive bladder market from 2005-2015. Included is a disease overview, product analysis, total market revenue forecasts, product revenue forecasts, patient forecasts and market share analysis. The market is segmented by product: Detrol, Detrol LA, Ditropan, Ditropan XL, Enablex, Oxytrol, Sanctura, Sanctura XR, VESIcare, and others. Major market challenges, drivers, and restraints and identified and discussed as well as pipeline by phase.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
|
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports,
company profiles and country profiles from over 700 research firms. Our reports will
provide you with the critical business and competitive intelligence you need for strategic planning and marketing
research. Coverage includes the US, UK, Europe, Asia and global markets.
© MarketResearch.com 2012
|
